TYRA BIOSCIENCES, INC. TYRA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.45M (1 inflow days, 19 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 50.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 16.24% to 14.40% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +2,670,887 | 4.9% |
| FMR | Mutual Fund | 2026/Q3 | +1,617,950 | 15.3% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +648,194 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +272,686 | 4.8% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +259,693 | 2.6% |
| BVF Partners L.P. | Hedge Fund | 2026/Q3 | +2,739,690 | 6.1% |
| Paradigm Biocapital Advisors LP | Hedge Fund | 2026/Q3 | +1,644,846 | 5.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +1,796,506 | 4.0% |
| FMR | Mutual Fund | 2026/Q3 | +1,172,865 | 13.0% |
| Hood River Capital Management LLC | Mutual Fund | 2026/Q3 | +1,016,775 | 1.5% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +924,290 | 3.1% |
| BlackRock | Mutual Fund | 2026/Q3 | +814,043 | 4.4% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +725,000 | 1.1% |
| Deerfield Management Company, L.P. | Hedge Fund | 2026/Q3 | +468,000 | 1.5% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +461,859 | 6.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | Alan Fuhrman | Chief Financial Officer | Other Acquisition | +951 | $9.13 | 17,115 |
| 14 Sep 2026 | RA Capital Management, L.P. | Open Market Derivative Acquisiti | +9,078,529 | $0.00 | 11,616,986 | |
| 14 Sep 2026 | Todd Harris | Chief Executive Officer | Other Acquisition | +864 | $9.13 | 1,359,495 |
| 14 Sep 2026 | Julia Rueb | VP of Finance & Principal Accounting Officer | Other Acquisition | +2,925 | $9.13 | 11,258 |
| 8 Sep 2026 | Rehan Verjee | Independent Director | Open Market Acquisition | +971 | $20.58 | 972 |
| 27 May 2026 | Robert J. More | Independent Director | Other Derivative Acquisition | +13,160 | $32.68 | 13,160 |
| 27 May 2026 | RA Capital Management, L.P. | Other Derivative Acquisition | +13,160 | $32.68 | 13,160 | |
| 27 May 2026 | Adele M. Gulfo | Independent Director | Other Derivative Acquisition | +13,160 | $32.68 | 13,160 |
| 27 May 2026 | Rehan Verjee | Independent Director | Other Derivative Acquisition | +13,160 | $32.68 | 13,160 |
| 27 May 2026 | S. Rothenberg | Independent Director | Other Derivative Acquisition | +13,160 | $32.68 | 13,160 |
| 27 May 2026 | Jake Simson | Independent Director | Other Derivative Acquisition | +13,160 | $32.68 | 13,160 |
| 27 May 2026 | Susan Moran | Independent Director | Other Derivative Acquisition | +13,160 | $32.68 | 13,160 |
| 4 May 2026 | Alan Fuhrman | Chief Financial Officer | Other Acquisition | +20,000 | – | 20,000 |
| 4 May 2026 | Alan Fuhrman | Chief Financial Officer | Other Derivative Acquisition | +67,000 | $33.93 | 67,000 |
| 4 May 2026 | Todd Harris | Chief Executive Officer | Other Acquisition | +79,000 | – | 79,000 |
| 4 May 2026 | Todd Harris | Chief Executive Officer | Other Derivative Acquisition | +265,000 | $33.93 | 265,000 |
| 4 May 2026 | Bhavesh Ashar | Chief Operating Officer | Other Acquisition | +15,013 | – | 15,013 |
| 4 May 2026 | Bhavesh Ashar | Chief Operating Officer | Other Derivative Acquisition | +50,295 | $33.93 | 50,295 |
| 4 May 2026 | Douglas Warner | Chief Medical Officer | Other Acquisition | +25,000 | – | 25,000 |
| 4 May 2026 | Douglas Warner | Chief Medical Officer | Other Derivative Acquisition | +85,000 | $33.93 | 85,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,901,757 | 14.4% | 15.3 |
| 15 Oct 2026 | 9,495,754 | 13.8% | 15.3 |
| 30 Sep 2026 | 9,414,018 | 13.7% | 8.8 |
| 15 Sep 2026 | 9,876,964 | 14.4% | 5.7 |
| 31 Aug 2026 | 9,440,216 | 15.8% | 27.1 |
| 14 Aug 2026 | 9,689,392 | 16.2% | 12.7 |
No comments yet — be the first to weigh in on TYRA.
Sign in to join the discussion.